"Graft Rejection" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient.
| Descriptor ID |
D006084
|
| MeSH Number(s) |
G12.875.545.328
|
| Concept/Terms |
Graft Rejection- Graft Rejection
- Graft Rejections
- Rejection, Graft
- Rejections, Graft
- Transplant Rejection
- Transplantation Rejection
- Rejection, Transplantation
- Rejections, Transplantation
- Transplantation Rejections
- Rejection, Transplant
- Rejections, Transplant
- Transplant Rejections
|
Below are MeSH descriptors whose meaning is more general than "Graft Rejection".
Below are MeSH descriptors whose meaning is more specific than "Graft Rejection".
This graph shows the total number of publications written about "Graft Rejection" by people in this website by year, and whether "Graft Rejection" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2006 | 2 | 0 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 2 | 2 |
| 2009 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 2 |
| 2014 | 2 | 1 | 3 |
| 2015 | 2 | 2 | 4 |
| 2016 | 1 | 1 | 2 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Graft Rejection" by people in Profiles.
-
Human antibody repertoire among kidney donors with and without HIV. JCI Insight. 2026 Apr 22; 11(8).
-
Safety of Kidney Transplantation from Donors with HIV. N Engl J Med. 2024 10 17; 391(15):1390-1401.
-
Should Pre-Transplant Hemoglobin A1c Be Used to Predict Post-Transplant Compliance in End-Stage Renal Disease Patients Undergoing Kidney Transplantation? Ann Transplant. 2020 Jun 26; 25:e924061.
-
Efficacy and safety of bleselumab in kidney transplant recipients: A phase 2, randomized, open-label, noninferiority study. Am J Transplant. 2020 01; 20(1):159-171.
-
Clinical relevance of lung-restricted antibodies in lung transplantation. Hum Immunol. 2019 Aug; 80(8):595-601.
-
Long-Term Impact of Cytomegalovirus Serologic Status on Lung Transplantation in the United States. Ann Thorac Surg. 2019 04; 107(4):1046-1052.
-
Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection. Hepatology. 2018 10; 68(4):1298-1307.
-
Pre-transplant depression as a predictor of adherence and morbidities after orthotopic heart transplantation. J Cardiothorac Surg. 2017 Jul 25; 12(1):62.
-
Cytomegalovirus and Other ?-Herpesviruses. Semin Nephrol. 2016 09; 36(5):351-361.
-
Anti-vimentin Antibodies Present at the Time of Transplantation May Predict Early Development of Interstitial Fibrosis/Tubular Atrophy. Transplant Proc. 2016 Jul-Aug; 48(6):2023-33.